Pure Global
NCT06303089

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients: A Cross-Sectional Study.
Sun Yat-sen University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Questionnaires set
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Mar 01, 2025
Enrollment
554 participants
Primary outcome

Prevalence of current smokers,Abstinence rates

Summary

The purpose of this study is to describe the tobacco exposure and characteristics of patients
 with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related
 knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking
 cessation.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06303089
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06303089 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 554 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.